A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation

PHASE2

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped After enrolment was complete, and sufficient data was collected to fully characterize the highest dose cohort, study follow up was terminated by the sponsor for non-safety related reasons.

Conditions

Kidney Transplantation

Interventions

BIOLOGICAL: TCD601
DRUG: Tacrolimus (TAC)
DRUG: Corticosteroids (CS)
DRUG: Mycophenolate Mofetil (MMF)
DRUG: ATG

Sponsor

ITB-Med LLC